Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc van Maanen

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Current HIV Research|March 27, 2004
Rodent models for HIV-1 infection and diseaseMarc van Maanen, Richard E Sutton
Expert Opinion on Biological Therapy|August 29, 2003
Genetic therapy for HIV/AIDSAnanthalakshmi Poluri, Marc van Maanen, Richard E Sutton
Journal of Virology|March 16, 2006
Human chromosome 2 carries a gene required for production of infectious human immunodeficiency virus type 1Ayse K Coskun, Marc van Maanen, Van Nguyen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 23, 2006
Vaccination of mice with replication-defective human immunodeficiency virus induces cellular and humoral immunity and protects against vaccinia virus-gag challengeChristopher S Baliga, Marc van Maanen, Michael Chastain, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 5, 2003
Development of an HIV-based cDNA expression cloning systemMarc van Maanen, Jennie K Tidwell, Lawrence A Donehower, et al.
Virology|February 3, 2007
Isolation and characterization of mouse-human microcell hybrid cell clones permissive for infectious HIV particle releaseAyse K Coskun, Marc van Maanen, David Janka, et al.
Molecular Carcinogenesis|May 3, 2006
Augmented cancer resistance and DNA damage response phenotypes in PPM1D null miceBonnie Nannenga, Xiongbin Lu, Melissa Dumble, et al.
Journal of Pharmaceutical Sciences|September 19, 2012
The impact of sialic acids on the pharmacokinetics of a PEGylated erythropoietinLiming Liu, Huijuan Li, Stephen R Hamilton, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Current HIV Research|March 27, 2004
Rodent models for HIV-1 infection and diseaseMarc van Maanen, Richard E Sutton
Expert Opinion on Biological Therapy|August 29, 2003
Genetic therapy for HIV/AIDSAnanthalakshmi Poluri, Marc van Maanen, Richard E Sutton
Journal of Virology|March 16, 2006
Human chromosome 2 carries a gene required for production of infectious human immunodeficiency virus type 1Ayse K Coskun, Marc van Maanen, Van Nguyen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 23, 2006
Vaccination of mice with replication-defective human immunodeficiency virus induces cellular and humoral immunity and protects against vaccinia virus-gag challengeChristopher S Baliga, Marc van Maanen, Michael Chastain, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 5, 2003
Development of an HIV-based cDNA expression cloning systemMarc van Maanen, Jennie K Tidwell, Lawrence A Donehower, et al.
Virology|February 3, 2007
Isolation and characterization of mouse-human microcell hybrid cell clones permissive for infectious HIV particle releaseAyse K Coskun, Marc van Maanen, David Janka, et al.
Molecular Carcinogenesis|May 3, 2006
Augmented cancer resistance and DNA damage response phenotypes in PPM1D null miceBonnie Nannenga, Xiongbin Lu, Melissa Dumble, et al.
Journal of Pharmaceutical Sciences|September 19, 2012
The impact of sialic acids on the pharmacokinetics of a PEGylated erythropoietinLiming Liu, Huijuan Li, Stephen R Hamilton, et al.
Pageof 1